Introduction
The incidence of invasive fungal infections (IFI) has been on the
rise due to increasing numbers of immunocompromised or severely
ill patients. This rise in incidence is accompanied by a
broadening range of fungal species causing potentially lethal disease
[1]. The subject of this report had a solitary pulmonary nodule,
which was initially suspected to be of malignant origin but
eventually was confirmed to be of fungal origin. To our knowledge,
this is the first report of an IFI caused by Talaromyces species (sp.)
that is successfully treated with voriconazole.